Intricon (IIN) Stock Price
Intricon Price
Over the last 19 years Intricon grew revenue by 3.5% annually, reaching 125.21 M USD. Earnings per share have grown at 33.8% per year over the last 8 years. For Intricon, the net margin of -0.1% is down versus 2.0% a few years ago.
Intricon stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Intricon over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Intricon stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Intricon's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Intricon Price |
|---|
Intricon Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Intricon Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022e | 2023e | 2024e | 2025e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58.00 | 56.00 | 63.00 | 52.00 | 68.00 | 69.00 | 68.00 | 88.00 | 116.00 | 113.00 | 102.00 | 125.00 | 136.00 | 161.00 | 183.00 | 209.00 |
| 13.73 | -3.45 | 12.50 | -17.46 | 30.77 | 1.47 | -1.45 | 29.41 | 31.82 | -2.59 | -9.73 | 22.55 | 8.80 | 18.38 | 13.66 | 14.21 |
| 25.86 | 21.43 | 22.22 | 23.08 | 26.47 | 27.54 | 25.00 | 29.55 | 31.90 | 26.55 | 25.49 | 24.80 | 24.80 | 24.80 | 24.80 | 24.80 |
| 15.00 | 12.00 | 14.00 | 12.00 | 18.00 | 19.00 | 17.00 | 26.00 | 37.00 | 30.00 | 26.00 | 31.00 | 33.73 | 39.93 | 45.38 | 51.83 |
| 1.00 | -1.00 | 1.00 | -1.00 | 3.00 | 2.00 | -3.00 | 2.00 | 7.00 | -2.00 | -3.00 | – | 4.00 | 10.00 | 23.00 | 55.00 |
| 1.72 | -1.79 | 1.59 | -1.92 | 4.41 | 2.90 | -4.41 | 2.27 | 6.03 | -1.77 | -2.94 | – | 2.94 | 6.21 | 12.57 | 26.32 |
| – | -1.00 | – | -6.00 | 2.00 | 2.00 | -4.00 | 1.00 | 5.00 | -3.00 | -2.00 | – | 4.00 | 9.00 | 24.00 | 61.00 |
| – | – | – | – | -133.33 | – | -300.00 | -125.00 | 400.00 | -160.00 | -33.33 | – | – | 125.00 | 166.67 | 154.17 |
| 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 7.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Intricon generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Intricon retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Intricon's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Intricon has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Intricon's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Intricon stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Intricon Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Intricon business model & stock analysis
Intricon SWOT Analysis
Strengths
IntriCon Corp possesses several strengths that contribute to its competitiveness in the market. These include:
1. Technological expertise: IntriCon Corp has a strong track record of developing advanced technologies in the field, which gives it a competitive edge over its rivals.
2. Diverse product portfolio: The company offers a wide range of products and solutions, catering to various customer demands. This diversification enables it to capture a larger market share.
3. Strong industry partnerships: IntriCon Corp has established strategic partnerships with key players in the industry, enhancing its distribution network and market reach.
Weaknesses
Despite its strengths, IntriCon Corp faces certain weaknesses that require attention and improvement:
1. Limited global presence: The company's operations are primarily concentrated in a few regions, limiting its exposure to potential international markets and opportunities.
2. Dependence on key customers: IntriCon Corp heavily relies on a few major customers for a significant portion of its revenue. This concentration poses a risk if those customers reduce or terminate their business with the company.
3. Relatively small scale: Compared to some larger competitors, IntriCon Corp operates on a smaller scale, potentially limiting its ability to invest in research and development or compete on pricing.
Opportunities
The following opportunities present growth potential for IntriCon Corp:
1. Growing healthcare market: The increasing demand for healthcare-related services and technologies opens doors for IntriCon Corp to expand its product offerings and enter new market segments.
2. Emerging markets: Rapid economic development in emerging markets offers opportunities for market expansion and revenue growth for IntriCon Corp, if it successfully taps into these regions.
3. Aging population: The global aging population requires innovative medical devices and solutions, providing a favorable market environment for IntriCon Corp to innovate and capitalize on.
Threats
IntriCon Corp faces several threats that could impact its business and performance:
1. Intense competition: The industry is highly competitive, with numerous established players and new entrants. IntriCon Corp needs to continuously enhance its products and services to stay ahead.
2. Regulatory challenges: Compliance with evolving laws and regulations in the healthcare industry can pose obstacles for IntriCon Corp, potentially impacting its operations and financials.
3. Economic uncertainties: Global economic fluctuations and recessions may affect consumer spending habits, potentially leading to reduced demand for IntriCon Corp's products.
Intricon Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Intricon Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Intricon historical P/E ratio, EBIT multiple, and P/S ratio
Intricon annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Intricon shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Intricon stock splits
Intricon Dividend History
2 years of dividend payments
Intricon Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 5/20/2020 | Maintained | Buy | 56 | |
| 5/20/2020 | Maintained | Buy | – | |
| 4/7/2020 | Maintained | Buy | – | |
| 2/25/2020 | Maintained | Buy | – | |
| 2/20/2020 | Maintained | Buy | – | |
| 1/4/2019 | Maintained | Buy | 55 | |
| 9/21/2018 | Maintained | Buy | 55 | |
| 9/11/2018 | Downgrade | BuyNeutral | 52 | |
| 8/22/2018 | Maintained | Buy | – | |
| 7/26/2018 | Maintained | Buy | 55 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Intricon Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 2/27/2023 | 0.16USD | - | 36.03 MUSD | - | 2022 Q4 |
| 11/29/2022 | 0.14USD | - | 35.63 MUSD | - | 2022 Q3 |
| 10/7/2022 | 0.11USD | - | 34.10 MUSD | - | 2022 Q2 |
| 6/3/2022 | 0.06USD | - | 33.09 MUSD | - | 2022 Q1 |
| 2/28/2022 | 0.01USD | - | 31.33 MUSD | - | 2021 Q4 |
| 11/8/2021 | 0.03USD | - | 30.75 MUSD | - | 2021 Q3 |
| 8/9/2021 | 0.08USD | - | 28.99 MUSD | - | 2021 Q2 |
| 5/10/2021 | 0.00USD | - | 27.15 MUSD | - | 2021 Q1 |
| 2/25/2021 | 0.04USD | - | 27.76 MUSD | - | 2020 Q4 |
| 11/9/2020 | -0.05USD | - | 24.91 MUSD | - | 2020 Q3 |
Intricon shareholder structure
| % | Name |
|---|---|
13.48220% | |
7.17386% | |
4.01838% | |
2.12543% | |
1.23575% | |
0.69663% |
Intricon Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
11.00% | SEC ↗ | |
11.00% | SEC ↗ | |
11.00% | SEC ↗ | |
8.03% | SEC ↗ | |
7.03% | SEC ↗ | |
5.90% | SEC ↗ | |
5.54% | SEC ↗ | |
5.45% | SEC ↗ | |
5.27% | SEC ↗ | |
5.20% | SEC ↗ |
Intricon Executives and Management Board
12 members · avg. age 62 · 25 % women
Mr. Scott Longval (44)
President, Chief Executive Officer, Director · since 2006
650,071.00 USD
Management
Mr. Michael Geraci (62)
Senior Vice President - Sales and Marketing
Mr. Dennis Gonsior (62)
Senior Vice President, Global Operations
Ms. Annalee Lutgen (40)
Interim Chief Financial Officer, Finance Director, Treasurer · since 2021
Mr. David Liebl
Vice President - Research & Development
Board of Directors
Mr. Mark Gorder (73)
Director · since 1996
Mr. Philip Smith (53)
Independent Chairman of the Board
Mr. Nicholas Giordano (78)
Independent Director
Mr. Raymond Huggenberger (62)
Independent Director
Mr. Robert Masucci (83)
Independent Director
Ms. Heather Rider (61)
Independent Director
Frequently asked questions about Intricon
IntriCon Corp primarily operates in the United States, however, it also has a significant presence in Asia, specifically in China. With its headquarters in Arden Hills, Minnesota, IntriCon Corp has expanded its manufacturing and development capabilities to meet the growing demand for its innovative medical and hearing healthcare solutions. By establishing strategic partnerships and global distribution channels, IntriCon Corp has successfully penetrated different regions and markets, allowing it to serve a diverse customer base.
The business model of IntriCon Corp is focused on designing, developing, and manufacturing miniature and micro-miniature body-worn devices. These devices include hearing aids, medical implants, and communication devices. The company has expertise in advanced technologies like microelectronics, telecommunications, and wireless communications. IntriCon Corp works closely with its customers to provide innovative solutions and customized products. With its commitment to quality and cutting-edge technology, IntriCon Corp aims to enhance the lives of individuals who benefit from its devices.
IntriCon Corp is primarily active in the healthcare industry. They specialize in providing miniature and micro-miniature body-worn devices and components, including hearing aids, diagnostic devices, and medical implants. With their focus on developing advanced technology solutions, IntriCon Corp aims to improve healthcare outcomes for individuals worldwide.
The main competitors of IntriCon Corp in the market include companies like Medtronic plc, Natus Medical Incorporated, and Sonova Holding AG.
IntriCon Corp., founded in 1930, is a leading provider of miniature and micro-miniature body-worn medical and electronics devices. The company has a diverse history, originally starting as a hearing aid components manufacturer. Over the years, IntriCon Corp. expanded its range of products and now specializes in advanced hearing health solutions, biomedical devices for diabetes management, and professional audio communication systems. With a strong focus on innovation and quality, IntriCon Corp. has established itself as a trusted partner for healthcare professionals and other industry stakeholders, continuously driving advancements in the field of medical technology.
IntriCon Corp has achieved several significant milestones in its history. The company has successfully expanded its product portfolio, introduced innovative technologies, and forged strategic partnerships. IntriCon has consistently demonstrated strong financial performance and sustained growth, which has resulted in its inclusion in prestigious indices such as the Russell 2000 and the MSCI Micro Cap. The company has also received recognition for its industry-leading solutions and best-in-class manufacturing capabilities. These achievements highlight IntriCon's commitment to delivering exceptional products and services to its customers while establishing itself as a prominent player in the market.
IntriCon Corp is committed to exceptional values and a strong corporate philosophy. The company believes in delivering high-quality and innovative solutions to its customers. IntriCon places great importance on integrity, accountability, and mutual respect in all aspects of its operations. With a focus on long-term partnerships, IntriCon strives to build strong relationships with customers, employees, and stakeholders. The company's dedication to quality, efficiency, and continuous improvement helps it stay at the forefront of its industry. IntriCon Corp values diversity and encourages collaboration and innovation to drive growth and achieve sustainable success.
5 analysts currently rate the Intricon stock: 4 recommend buying, 1 holding and 0 selling.
The Intricon share (IIN) is listed on 1 stock exchanges, including: NASDAQ (IIN).
IntriCon Corp is a globally operating company specializing in the development and manufacture of micro and miniature components for various industries. The company operates in three main divisions: hearing aid technology, audiology and mobile hearing aids, and medical technology. The focus is on the development and production of components such as microphones, switches, batteries, cables, amplifiers, filter systems, and much more. IntriCon Corp works closely with its customers to deliver customized solutions for their needs. The company has earned an excellent reputation, especially in the field of hearing aid technology. In the hearing aid technology division, IntriCon Corp offers a wide range of products, including hearing aid accessories and sound tubes. These products are used by many leading hearing aid manufacturers to improve the quality of their devices and optimize the listening experience for their customers. In audiology and mobile hearing aid technology, IntriCon Corp develops and manufactures innovative components for wireless hearing aids. These products are used by hearing aid manufacturers and audiologists to wirelessly connect the hearing aids with other devices such as cell phones, televisions, or computers. This feature significantly improves the sound quality and listening experience for the user. In the medical technology division, IntriCon Corp offers solutions for medical facilities, including HF surgery devices, anesthesia devices, and patient monitors. The company also develops and manufactures various components such as cables and sensors for this field. In addition, IntriCon Corp also offers customized solutions for various industries, including telecommunications, industrial automation, and measuring devices. Overall, the business model of IntriCon Corp is characterized by its high innovation and flexibility. The company places great importance on working closely with its customers to create customized solutions for their needs. It always keeps an eye on the latest developments and technical standards to ensure a high quality of its products for its customers. In summary, IntriCon Corp is a globally operating company specializing in the development and manufacture of micro and miniature components for various industries. The company operates in three main divisions: hearing aid technology, audiology and mobile hearing aids, and medical technology. IntriCon Corp offers a wide range of products tailored to customer needs. The company is innovative and technologically advanced to ensure a high quality of its products.
The revenue cannot currently be calculated for Intricon.
The profit cannot currently be calculated for Intricon.
The P/E ratio cannot be calculated for Intricon at the moment.
The P/S cannot be calculated for Intricon currently.
The Eulerpool Quality Score for Intricon is 3/10.
The ISIN of Intricon is US46121H1095. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Intricon is A0D9UU. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Intricon is IIN. The ticker symbol is used to trade Intricon shares on the stock exchange.
Intricon is assigned to the 'Health' sector.
The dividends of Intricon are distributed in USD.
Intricon stock
Intricon Peer Group
Intricon Ticker
Intricon FIGI
All fundamentals and in-depth analysis of Intricon
Our stock analysis for Intricon stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Intricon. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.